Almirall (XMAD:ALM) Other Income (Expense) : €-4.8 Mil (TTM As of Jun. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Almirall Other Income (Expense)?

Almirall's other income expense for the Almirall's pretax income for the three months ended in Jun. 2023 was €-35.9 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2023 was €-4.8 Mil.

Almirall Other Income (Expense) Historical Data

The historical data trend for Almirall's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall Other Income (Expense) Chart

Almirall Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

Get a 7-Day Free Trial

-873.88

-13.48

-99.45

-25.12

-52.89

Almirall Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23
Other Income (Expense)	Get a 7-Day Free Trial															-32.20	-	31.10	-35.86	-

Almirall Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-4.8 Mil.

Almirall (XMAD:ALM) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Almirall (XMAD:ALM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (XMAD:ALM) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

LBTSF:USA 0O9B:UK E2Z:Germany

Address

Ronda General Mitre 151, Barcelona, ESP, 08022

Website

http://www.almirall.es

Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.

Almirall (XMAD:ALM) Headlines

From GuruFocus

ALFI Inc: A Little Known Yet Compelling Ad-Tech Play

By Ishan Majumdar Ishan Majumdar • 05-07-2021

Alfi: Solid Growth Potential Lies Ahead

By Ishan Majumdar Ishan Majumdar • 06-02-2021